This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Following Recent Completion of Clinical Study for PSA test and with upcoming modular PMA to FDA, We Take a Deeper Look at OPKO Health’s Claros 1 Point of Care Testing Device

Ticker(s): OPK, ALR

Who's the expert?

An esoteric/genetic testing expert or urologist familiar with the CLAROS 1 platform.

Interview Questions

Please describe the current PSA screening testing environment. How many tests do you perform each month?

Added By: c_admin

While standard total PSA testing has been around for over a decade, it can take between 24-72 hours for the results, and Claros removes the need for a venipuncture. Would that be sufficient to make you switch over to using Claros 1?

Added By: c_admin

The Claros 1 instrument will cost about $2,500, and will also be available under a reagent rental agreement. The cassettes will cost about $10-$15 per cassette, depending on the test. How do you anticipate payor reimbursement for this test?

Added By: c_admin

Do you currently use the 4Kscore test?

Added By: c_admin

On a scale from 1-10, 10 being very excited, where would you rate your level of excitement for the CLAROS 1 testing platform if approved?

Added By: c_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.


*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.